O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)
| Autor: | Pfeiffer, P., Yilmaz, M., Nordsmark, M., Möller, S., Elle, I., Ladekarl, M., Winther, S., Qvortrup, C., Baeksgaard, L. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Pfeiffer, P, Yilmaz, M, Nordsmark, M, Möller, S, Elle, I, Ladekarl, M, Winther, S, Qvortrup, C & Baeksgaard, L 2022, ' O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas) ', Annals of Oncology, vol. 33, no. Suppl. 4, pp. S380 . https://doi.org/10.1016/j.annonc.2022.04.445 |
| DOI: | 10.1016/j.annonc.2022.04.445 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|